Provider review
Revel Health review
Shows the first-month price and the standing rate together on every single line.
Four products, four pairs, no exceptions — the step you would otherwise meet at the second charge.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Revel Health
$199/mo semaglutide standing, $99 first month
- Vs median
- $30/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The commonest way anyone in this category gets caught out is an introductory price presented as though it were the ongoing one. Revel publishes both, on every line, in the same place: four products, four pairs, no exceptions. That makes the whole catalog readable at a glance, and it is rare enough to be the main reason to look here at all. What the figure buys is stated too — consultation, medication, supplies and shipping — so there is no second bill waiting behind it. The weakness is the ordinary one and it is milder here than most. Each standing rate is introduced as a From price, so it is the bottom of a range whose upper rungs are not published, and if your dose rises you cannot tell from the page what changes. Nothing is said about milligrams anywhere, which means the flat-looking structure cannot be checked against a quantity of drug.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want to see the second-month price before you pay the first
- You want consultation, medication, supplies and shipping inside one figure
- You are comparing several products from one provider on the same basis
Look elsewhere if
- You want to know what a higher dose costs. Only the entry rate is published
- You want the introductory rate to last longer than a month
- You want a dose behind the number
What it actually costs
Price as published
★★ EVERY PRODUCT SHOWS BOTH NUMBERS, which almost nothing else here does even once: semaglutide injection "From $199/mo" with "First month $99", tirzepatide injection "From $249/mo" with "First month $149", NAD+ injection "From $169/mo" with "First month $119", sermorelin injection "From $149/mo" with "First month $99" · so the step from the introductory rate to the standing one is visible on the card for all four lines rather than discovered at the second charge · everything is stated as included — "consultation, medication, supplies, and shipping" · each standing figure is still introduced by "From", so it is a floor and no rung above it is published · no milligram is published against any line
- Vs median
- $30/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. ★★ The introductory price and the standing rate sit together on EVERY line, all four products, no exceptions. The commonest way a reader here is caught out is an intro rate presented as the ongoing one, and this catalog removes that failure entirely. No low-dose product exists and no dose is published, and each standing rate is a floor with no rung above it, so what happens as the dose rises is still unknown.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Shows the introductory price and the standing rate together on every product.
- Consultation, medication, supplies and shipping are all named as included.
- Four lines priced the same consistent way, so the catalog is comparable within itself.
Pharmacy, labs and oversight
Revel Health does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What Revel Health publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
The single commonest way a reader in this category is caught out is an introductory price presented as if it were the ongoing one. Revel publishes both, on every line, in the same place — four products, four pairs, no exceptions. That makes the whole catalog readable at a glance in a way that is rare enough to be the main reason to consider it. What it buys is stated too: consultation, medication, supplies and shipping in the figure. The weakness is the usual one and it is milder than most. Each standing rate is introduced as a From price, so it is the bottom of a range whose upper rungs are not published, and a reader at a higher dose cannot tell from the page what changes. Nothing is said about milligrams anywhere.
The honest cons
Every standing rate is a floor with no rung above it published.
- No milligram appears against any figure.
- The introductory rate applies to one month only, on all four lines.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Revel Health is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#307 of 373
Ordered with the companies that pay us first, and Revel Health is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.